The mechanism of action of probiotics
暂无分享,去创建一个
[1] F. Obermeier,et al. Surface Expression of Toll-Like Receptor 9 Is Upregulated on Intestinal Epithelial Cells in Response to Pathogenic Bacterial DNA , 2007, Infection and Immunity.
[2] M. Weichenthal,et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] Le Shen,et al. A porous defense: the leaky epithelial barrier in intestinal disease , 2004, Laboratory Investigation.
[4] M. Weichenthal,et al. Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .
[5] A. Fanning,et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius , 2006, Immunology.
[6] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[7] O. Dewit,et al. Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection , 2007 .
[8] D. Graham,et al. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. , 2001, Alimentary pharmacology & therapeutics.
[9] D. Hommes,et al. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. , 2004, The American journal of clinical nutrition.
[10] R. Hershberg. The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[11] M. Gotteland,et al. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? , 2006, Alimentary pharmacology & therapeutics.
[12] Tomohiro Watanabe,et al. Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.
[13] S. Colgan,et al. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. , 1998, Journal of immunology.
[14] T. Tompkins,et al. Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements , 2005, Infection and Immunity.
[15] K. Madsen,et al. Probiotics and prebiotics in gastrointestinal disorders , 2004, Current opinion in gastroenterology.
[16] G. Vinderola,et al. Role of Intestinal Epithelial Cells in Immune Effects Mediated by Gram-Positive Probiotic Bacteria: Involvement of Toll-Like Receptors , 2005, Clinical Diagnostic Laboratory Immunology.
[17] M. Selsted,et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. , 2000, Nature immunology.
[18] D. Graham,et al. Mycobacterium avium subsp. paratuberculosis as one cause of Crohn’s disease , 2001 .
[19] J. Coppee,et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. , 2006, The Journal of Immunology.
[20] M. Zeitz,et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.
[21] L. van Lieshout,et al. Pouchitis: result of microbial imbalance? , 1994, Gut.
[22] M. Yazdanbakhsh,et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. , 2005, The Journal of allergy and clinical immunology.
[23] K. Madsen,et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.
[24] D. D. Jong,et al. NOD 2 mediates anti-inflammatory signals induced byTLR 2 ligands : implications for Crohn ’ s disease , 2004 .
[25] J. Bertin,et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. , 2001, EMBO reports.
[26] H. Qin,et al. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. , 2005, World journal of gastroenterology.
[27] J. Coppee,et al. Anti-Inflammatory Effect of Lactobacillus casei on Shigella-Infected Human Intestinal Epithelial Cells1 , 2006, The Journal of Immunology.
[28] J. Bertin,et al. CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri , 2001 .
[29] C. Pothoulakis,et al. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. , 2006, Biochemical and biophysical research communications.
[30] P. Rutgeerts,et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.
[31] J. Chang,et al. Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha. , 2007, World journal of gastroenterology.
[32] D. Haller,et al. Innate mechanisms for Bifidobacterium lactis to activate transient pro‐inflammatory host responses in intestinal epithelial cells after the colonization of germ‐free rats , 2005, Immunology.
[33] J. Gordon,et al. Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.
[34] T. Giese,et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.
[35] E. Schiffrin,et al. Induction by a Lactic Acid Bacterium of a Population of CD4+ T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor β and Interleukin-10 , 2001, Clinical Diagnostic Laboratory Immunology.
[36] R. Sartor,et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment , 2000, Gut.
[37] S. Akira,et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. , 2004, Gastroenterology.
[38] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[39] M. Kleerebezem,et al. Towards understanding molecular modes of probiotic action. , 2006, Current opinion in biotechnology.
[40] J. Söderholm,et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. , 2002, Gastroenterology.
[41] M. Jakobsen,et al. Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. , 2007, Antiviral research.
[42] M. Abreu,et al. TLR Signaling in the Gut in Health and Disease1 , 2005, The Journal of Immunology.
[43] I. Autenrieth,et al. Identification of Commensal Bacterial Strains That Modulate Yersinia enterocolitica and Dextran Sodium Sulfate-Induced Inflammatory Responses: Implications for the Development of Probiotics , 2007, Infection and Immunity.
[44] J. Neu,et al. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. , 2005, The Journal of nutrition.
[45] E. Mayer,et al. The neurobiology of stress and gastrointestinal disease , 2000, Gut.
[46] G. Ruthel,et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] F. Brennan,et al. IL-10 gene therapy prevents TNBS-induced colitis , 2002, Gene Therapy.
[48] D. Haller,et al. IL-10 Gene-Deficient Mice Lack TGF-β/Smad Signaling and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells after the Colonization with Colitogenic Enterococcus faecalis1 , 2005, The Journal of Immunology.
[49] A. Macpherson,et al. Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.
[50] Tomohiro Watanabe,et al. NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.
[51] C. De Simone,et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. , 2001, Gastroenterology.
[52] H. Kiyono,et al. Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. , 2007, Clinical immunology.
[53] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[54] C. Dejong,et al. Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock , 2005, Infection and Immunity.
[55] M Schwab,et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.
[56] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[57] F. Shanahan,et al. Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.
[58] K. Barrett,et al. Probiotics and Commensals Reverse TNF-α– and IFN-γ–Induced Dysfunction in Human Intestinal Epithelial Cells , 2003 .
[59] D. McKay,et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress , 2006, Gut.
[60] M. Washington,et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.
[61] R. Sartor,et al. Probiotic therapy of intestinal inflammation and infections , 2005, Current opinion in gastroenterology.
[62] J. Söderholm,et al. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[63] R. Geffers,et al. The host response to the probiotic Escherichia coli strain Nissle 1917: Specific up-regulation of the proinflammatory chemokine MCP-1 , 2005, BMC Medical Genetics.
[64] John Bertin,et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.
[65] W. Strober,et al. Insights into the Mechanism of Oral Tolerance Derived from the Study of Models of Mucosal Inflammation , 2004, Annals of the New York Academy of Sciences.
[66] K. Madsen,et al. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. , 2005, Current opinion in pharmacology.
[67] K. Takeda,et al. Interleukin‐12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota , 2006, Clinical and experimental immunology.
[68] P. Scully,et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[69] R. Blumberg,et al. The immunology of mucosal models of inflammation. , 2002, Annual review of immunology.
[70] K. Fellermann,et al. Induction of Human β-Defensin 2 by the Probiotic Escherichia coli Nissle 1917 Is Mediated through Flagellin , 2007, Infection and Immunity.
[71] R. Greenstein. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. , 2003, The Lancet. Infectious diseases.
[72] F. Caprioli,et al. Lactobacillus paracasei subsp. paracasei B21060 Suppresses Human T-Cell Proliferation , 2007, Infection and Immunity.
[73] J. Sirard,et al. A Key Role of Dendritic Cells in Probiotic Functionality , 2007, PloS one.
[74] G. Reid,et al. G‐CSF‐mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus‐induced suppression of TNF production in macrophages , 2006, Cellular microbiology.
[75] P. Felsburg,et al. Different cytokine response of primary colonic epithelial cells to commensal bacteria. , 2005, World journal of gastroenterology.
[76] Jongdae Lee,et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. , 2002, Gastroenterology.
[77] M. Marinaro,et al. Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells1 , 2005, The Journal of Immunology.
[78] B. Lacy,et al. The Interrelated Roles of TGF-β and IL-10 in the Regulation of Experimental Colitis , 2002, The Journal of Immunology.
[79] J. Söderholm,et al. Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats , 2004, Gut.
[80] Tomohiro Watanabe,et al. Following the TRAIL from hepatitis C virus and alcohol to fatty liver , 2005, Gut.
[81] J. Cheville,et al. Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. , 2003, Clinical medicine & research.
[82] G. Bouma,et al. The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.
[83] B. Franke,et al. NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease , 2004, European journal of immunology.
[84] S. Collins. Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[85] Beatrice Vitali,et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. , 2003, FEMS immunology and medical microbiology.
[86] L. Eckmann,et al. Amendment history : Corrigendum ( April 2005 ) Toll-like receptor 9 – induced type I IFN protects mice from experimental colitis , 2018 .
[87] L. Matrisian,et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.
[88] A. Darfeuille‐Michaud,et al. Lactobacillus casei DN-114 001 Inhibits the Ability of Adherent-Invasive Escherichia coli Isolated from Crohn's Disease Patients To Adhere to and To Invade Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.
[89] J. Pestka,et al. Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells1 , 2002, The Journal of Immunology.
[90] F. Shanahan,et al. Role of interleukin (IL‐10) in probiotic‐mediated immune modulation: an assessment in wild‐type and IL‐10 knock‐out mice , 2006, Clinical and experimental immunology.
[91] P. Brigidi,et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria , 2004, Gut.
[92] M. Schmidt,et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair , 2007, Cellular microbiology.
[93] F. Guarner,et al. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[94] A. Levine,et al. Maturation of the mucosal immune system underlies colitis susceptibility in interleukin‐10‐deficient (IL‐10−/−) mice , 2007, Journal of leukocyte biology.